Nektar TherapeuticsNKTRNASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Over Time
Trending higher, below historical average, structural decline.
Left:
||||
Revenue minus cost of goods sold
Latest
$67.74M
↓ 70% below average
Average (9y)
$227.33M
Historical baseline
Range
High:$1.17B
Low:$53.48M
CAGR
-11.2%
Structural decline
| Period | Value | Change |
|---|---|---|
| 2024 | $67.74M | +26.7% |
| 2023 | $53.48M | -24.1% |
| 2022 | $70.42M | -8.6% |
| 2021 | $77.01M | -42.3% |
| 2020 | $133.44M | +43.1% |
| 2019 | $93.24M | -92.0% |
| 2018 | $1.17B | +321.7% |
| 2017 | $277.16M | +105.0% |
| 2016 | $135.22M | -31.2% |
| 2015 | $196.68M | - |